J. MATTHEW SINGLETON - 02 Jan 2025 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
4
Filing time
06 Jan 2025, 20:13:34 UTC
Previous filing
25 Oct 2024
Next filing
05 Jan 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Award $0 +18,800 $0.000000 18,800 02 Jan 2025 Common Stock 18,800 $41.12 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.